These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 122781)
21. Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration. LeJemtel TH; Keung EC; Schwartz WJ; Maskin CS; Greenberg MA; Davis RS; Forman R; Ribner HS; Sonnenblick EH Trans Assoc Am Physicians; 1979; 92():325-33. PubMed ID: 549256 [No Abstract] [Full Text] [Related]
22. [Comparison of the action of Cordemcura on selected cardiovascular parameters following intraduodenal and intravenous application in beagles]. Hübler D; Mudhaffar AA; Schilling G; Elze M; Chemnitius KH Pharmazie; 1986 Mar; 41(3):196-9. PubMed ID: 3714795 [TBL] [Abstract][Full Text] [Related]
23. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure. Hauf GF; Bubenheimer P; Roskamm H Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235 [TBL] [Abstract][Full Text] [Related]
24. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?]. Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699 [TBL] [Abstract][Full Text] [Related]
25. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure. Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787 [TBL] [Abstract][Full Text] [Related]
26. In-vivo effects of amrinone and milrinone on left ventricular dP/dt, intraventricular pressure and heart rate in pentobarbital-anesthetized guinea pigs. Lin BB; Chen HL Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):237-40. PubMed ID: 1811284 [TBL] [Abstract][Full Text] [Related]
27. [Oral and injectable amrinone in cardiac insufficiency]. Massabuau P; Puel J; Miquel JP; Bounhoure JP Ann Cardiol Angeiol (Paris); 1984; 33(4):223-6. PubMed ID: 6465816 [TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals. Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464 [TBL] [Abstract][Full Text] [Related]
29. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure]. Saborowski F; Peters P; Schneider M Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900 [TBL] [Abstract][Full Text] [Related]
30. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043. Uretsky BF; Valdes AM; Reddy PS Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs. Yi GH; Burkhoff D; Zhang H; Zhu SM; Zwas D; Wang J J Pharmacol Exp Ther; 1998 Aug; 286(2):760-6. PubMed ID: 9694931 [TBL] [Abstract][Full Text] [Related]
32. [Determination of active components of amrinone by analysis of pressure-volume results; use of the conductance (volume) catheter technic and rapid load change by balloon occlusion of the inferior vena cava]. Thormann J; Kramer W; Kindler M; Kremer P; Schlepper M Z Kardiol; 1987 Sep; 76(9):530-40. PubMed ID: 3424908 [TBL] [Abstract][Full Text] [Related]
33. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs. Pagel PS; Harkin CP; Hettrick DA; Warltier DC J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540 [TBL] [Abstract][Full Text] [Related]
34. [Amrinone in catecholamine refractory heart failure in septic shock]. Hoffmann P; Schockenhoff B Anaesthesist; 1985 Dec; 34(12):663-9. PubMed ID: 4096358 [TBL] [Abstract][Full Text] [Related]
35. Hemodynamic profile of the cardiotonic agent pimobendan. van Meel JC; Diederen W J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784 [TBL] [Abstract][Full Text] [Related]
36. Acute haemodynamic effects of intravenous amrinone in chronic congestive heart failure. Bahl VK; Khalilullah M Indian Heart J; 1984; 36(6):369-74. PubMed ID: 6535755 [No Abstract] [Full Text] [Related]
37. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients. Stauch M; Nechwatal W Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239 [TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of a new antiarrhythmic agent: cibenzoline. Rigaud M; Jouret G; Canal M; Bardet J; Flouvat B; Bourdarias JP J Pharmacol; 1985; 16(3):247-57. PubMed ID: 4068726 [TBL] [Abstract][Full Text] [Related]
39. [End-systolic pressure-volume relationships obtained by conductance catheter and transient inferior vena caval occlusion: their clinical usefulness]. Kameyama T; Asanoi H; Ishizaka S; Nozawa T; Fujita M; Sasayama S J Cardiol; 1991; 21(2):473-80. PubMed ID: 1668750 [TBL] [Abstract][Full Text] [Related]
40. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]